Men with metastatic castration-resistant prostate cancer should be treated primarily with second-generation hormone drugs, which offer better treatment response and longer life expectancy than chemotherapy. However,...
In a recent study published in the journal JAMA Network Open, researchers conducted a cross-sectional study of midlife-aged Black and White women to evaluate the impacts...
Those living in disadvantaged neighborhoods have significantly higher activity of stress-related genes, new research suggests, which could contribute to higher rates of aggressive prostate cancer in...
A recent study conducted by Helmholtz Munich and the German Center for Diabetes Research provides new insights into how fathers’ diets and overweight can affect their...